Company: ATRA
Filing Date: 2025-07-14
Form Type: 8-K
Source: 0001193125-25-158719
Chunk: 2

Company: Atara Biotherapeutics, Inc.
Filing Date: 2025-07-14
Form: 8-K
Item: Item 9.01
Chunk 2
---
Item 9.01 Financial Statements and Exhibits

(d) Exhibits.

  Exhibit      Description                                                                   
                                                                                             
      No.                                                                                    
     99.1      Press release, dated July 14, 2025                                            
 ─────────────────────────────────────────────────────────────────────────────────────────────
      104      Cover Page Interactive Data File (embedded within the Inline XBRL document).  

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                                    ATARA BIOTHERAPEUTICS, INC.            
  Date: July 14, 2025      By:      /s/ AnhCo Nguyen Ph. D.                
                                    AnhCo Nguyen, Ph. D.                   
                                    President and Chief Executive Officer